Skip to main content
. 2015 Oct 9;2:151–157. doi: 10.2147/JHC.S75153

Figure 3.

Figure 3

Overall survival of patients with FLC or HCC managed with a liver-directed procedure from the time of diagnosis in SEER from 1986 to 2008.

Notes: FLC (n=90; median survival: 75 months). HCC (n=7,135; median survival: 43 months). P=0.001. Reprinted from Journal of the American College of Surgeons, 218(2), Mayo SC, Mavros MN, Nathan H, et al, Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective, 196–205, Copyright © 2014, with permission from Elsevier.70

Abbreviations: FLC, fibrolamellar carcinoma; HCC, hepatocellular carcinoma; SEER, Surveillance, Epidemiology, and End Results Program.